Specific treatment, either by ADX or by MRA, was followed by a highly significant decrease in 24-h urinary calcium excretion, which was shown to be associated with improved bone health [ 14 ].
← all excerpts
Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism.
1
—
—